VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K902. A total of 6 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $630,000 | -98.5% | 45,800 | -98.2% | 0.00% | -100.0% |
Q2 2017 | $42,904,000 | +56.8% | 2,480,000 | 0.0% | 0.01% | +66.7% |
Q1 2017 | $27,354,000 | +224.8% | 2,480,000 | +327.6% | 0.01% | +200.0% |
Q4 2016 | $8,422,000 | -40.9% | 580,000 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $14,239,000 | +497.0% | 580,000 | +539.5% | 0.00% | +300.0% |
Q1 2016 | $2,385,000 | -98.9% | 90,700 | -95.9% | 0.00% | -98.2% |
Q4 2015 | $223,630,000 | +334.1% | 2,200,000 | +661.8% | 0.06% | +300.0% |
Q3 2015 | $51,516,000 | – | 288,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 1,425 | $12,266,000 | 0.82% |
GROUP ONE TRADING, L.P. | 127,400 | $10,967,000 | 0.27% |
KNIGHT CAPITAL GROUP LLC | 23,200 | $1,997,000 | 0.04% |
Timber Hill LLC | 92,700 | $7,980,000 | 0.03% |
Citadel Advisors | 131,000 | $11,276,000 | 0.02% |